Sartorius Aktiengesellschaft (SOAGY) Stock Price, News & Analysis

Company Overview

Sartorius Aktiengesellschaft is a leading international supplier of laboratory and bioprocessing equipment and services that support the biopharmaceutical industry. The company develops, manufactures and sells an extensive range of products designed to enhance drug discovery, development and production efficiency. Its portfolio includes single‐use bioreactors, filtration systems, cell culture media, laboratory balances, pipettes, consumables and software solutions that help customers accelerate and optimize research and manufacturing workflows.

The company operates through two primary divisions: Bioprocess Solutions and Lab Products & Services. Bioprocess Solutions delivers components and systems for upstream and downstream bioprocessing, including fermentation and purification equipment used in the manufacture of vaccines, monoclonal antibodies and advanced therapies. The Lab Products & Services segment offers precision instruments, consumables and related services for laboratories in academia, industry and quality control environments, covering sample preparation, cell analysis and general laboratory workflows.

Founded in 1870 in Göttingen, Germany, by Florenz Sartorius, the business has grown from a regional scale manufacturer of precision weighing devices into a global partner for life sciences and pharmaceutical companies. Over the decades, Sartorius expanded its product range through organic investment and strategic acquisitions, establishing research and production sites across Europe, North America and the Asia‐Pacific region. Today, the company’s solutions are used by researchers and manufacturers in more than 110 countries, reinforcing its reputation for quality, innovation and regulatory compliance.

Headquartered in Göttingen, Sartorius Aktiengesellschaft is led by an executive board chaired by Dr. Joachim Kreuzburg, who oversees strategy, technology development and global operations. The supervisory board and management team emphasize sustainability, digitalization and customer focus as core pillars of the company’s long‐term growth plan. Through ongoing R&D investment and close collaboration with academic and industrial partners, Sartorius continues to advance bioprocess and laboratory technologies that address evolving challenges in healthcare and life sciences.

Key Stats

• Today's Range: $53.94 to $54.72
• 50-Day Range: $48.35 to $58.10
• 52-Week Range: $43.72 to $62.15
• Volume: 2,555 shs
• Average Volume: 9,545 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SOAGY
• CIK: 1715801
• Web: www.sartorius.com
• Phone: 49-551-308-0
• Fax: N/A
• Employees: 14,614
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A